Cannabidiol markedly alleviates skin and liver fibrosis

Cannabidiol (CBD) has been suggested as a potential therapy for inflammatory and fibrotic diseases. Cannabidiol was demonstrated to reduce alcohol-induced liver inflammation and steatosis but its specific activity on the fibrotic process was not investigated. Herein, the antifibrotic effects of cann...

Descripción completa

Detalles Bibliográficos
Autores principales: del Río, Carmen, Ruiz-Pino, Francisco, Prados, María E., Fiebich, Bernd L., Tena-Sempere, Manuel, Muñoz, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627610/
https://www.ncbi.nlm.nih.gov/pubmed/36339540
http://dx.doi.org/10.3389/fphar.2022.981817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627610/
https://www.ncbi.nlm.nih.gov/pubmed/36339540
http://dx.doi.org/10.3389/fphar.2022.981817

Ejemplares similares